We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 0.88% | 28.75 | 28.50 | 29.00 | 28.75 | 28.75 | 28.75 | 365,308 | 08:00:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 48.48M | -776k | -0.0011 | -261.36 | 194.08M |
TIDMHVO
RNS Number : 0122O
hVIVO plc
24 January 2019
HVIVO PLC
("hVIVO" or the "Company")
Share Incentive Plan and PDMR Dealings
London, UK, 24 January 2019: hVIVO plc (AIM: HVO), an industry leading clinical development services business pioneering human disease models based upon viral and allergen challenge, announces that as part of the Company's commitment to encouraging all employees to be shareholders in the business, a total of 1,689,258 Ordinary Shares of 5 pence each (the "New Ordinary Shares") have been granted to employees pursuant to a new employee share incentive plan introduced by hVIVO on 21 January 2019 (the "Share Incentive Plan").
A total of 138 employees were found eligible and applied for the Share Incentive Plan and have been granted 12,241 free Ordinary Shares each representing approximately GBP3,600 at the purchase price. The free shares were awarded on 21 January 2019 and are subject to a 3 year forfeiture period.
Application has been made to AIM for the admission of the New Ordinary Shares ("Admission"), which will rank pari passu in all respects with the Company's existing shares in issue, and Admission is expected to occur on 25 January 2019.
Following Admission, the total number of ordinary shares with voting rights in issue will be 82,296,965 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
Dr Trevor Phillips (Executive Chairman), Tim Sharpington (COO, PDMR) and Shelley Fraser (Finance Director, PDMR) have been allotted 12,241 shares each, see below for further details.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 Details of the persons discharging managerial responsibilities/persons closely associated a) Name Trevor Phillips --------------------- -------------------------------------------------- 2 Reason for the notification ------------------------------------------------------------------------- a) Position/ Executive Chairman status --------------------- -------------------------------------------------- b) Initial Initial Notification notification/ Amendment --------------------- -------------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------- a) Name hVIVO plc --------------------- -------------------------------------------------- b) Legal Entity N/A Identifier --------------------- -------------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------------- a) Description Ordinary shares of 5 pence each of the financial instrument, type of GB00B6ZM0X53 instrument Identification code --------------------- -------------------------------------------------- b) Nature of Award of ordinary shares pursuant to Share the transaction Incentive Plan --------------------- -------------------------------------------------- c) Currency GBP --------------------- -------------------------------------------------- d) Price(s) Director Price (p) Volume and volume(s) Trevor Phillips 29.41p 12,241 ---------- ------- --------------------- e) Aggregated information - Aggregated volume - Price 12,241 - Aggregated 29.41p total GBP3,600 --------------------- -------------------------------------------------- f) Date of 21 January 2019 the transaction --------------------- -------------------------------------------------- g) Place of London Stock Exchange, AIM the transaction --------------------- -------------------------------------------------- 1 Details of the persons discharging managerial responsibilities/persons closely associated a) Name Tim Sharpington --------------------- -------------------------------------------------- 2 Reason for the notification ------------------------------------------------------------------------- a) Position/ COO, PDMR status --------------------- -------------------------------------------------- b) Initial Initial Notification notification/ Amendment --------------------- -------------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------- a) Name hVIVO plc --------------------- -------------------------------------------------- b) Legal Entity N/A Identifier --------------------- -------------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------------- a) Description Ordinary shares of 5 pence each of the financial instrument, type of GB00B6ZM0X53 instrument Identification code --------------------- -------------------------------------------------- b) Nature of Award of ordinary shares pursuant to Share the transaction Incentive Plan --------------------- -------------------------------------------------- c) Currency GBP --------------------- -------------------------------------------------- d) Price(s) Director Price (p) Volume and volume(s) Tim Sharpington 29.41p 12,241 ---------- ------- --------------------- e) Aggregated information - Aggregated volume - Price 12,241 - Aggregated 29.41p total GBP3,600 --------------------- -------------------------------------------------- f) Date of 21 January 2019 the transaction --------------------- -------------------------------------------------- g) Place of London Stock Exchange, AIM the transaction --------------------- -------------------------------------------------- 1 Details of the persons discharging managerial responsibilities/persons closely associated a) Name Shelley Fraser --------------------- -------------------------------------------------- 2 Reason for the notification ------------------------------------------------------------------------- a) Position/ Finance Director, PDMR status --------------------- -------------------------------------------------- b) Initial Initial Notification notification/ Amendment --------------------- -------------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------- a) Name hVIVO plc --------------------- -------------------------------------------------- b) Legal Entity N/A Identifier --------------------- -------------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------------- a) Description Ordinary shares of 5 pence each of the financial instrument, type of GB00B6ZM0X53 instrument Identification code --------------------- -------------------------------------------------- b) Nature of Award of ordinary shares pursuant to Share the transaction Incentive Plan --------------------- -------------------------------------------------- c) Currency GBP --------------------- -------------------------------------------------- d) Price(s) Director Price (p) Volume and volume(s) Shelley Fraser 29.41p 12,241 ---------- ------- --------------------- e) Aggregated information - Aggregated volume
- Price 12,241 - Aggregated 29.41p total GBP3,600 --------------------- -------------------------------------------------- f) Date of 21 January 2019 the transaction --------------------- -------------------------------------------------- g) Place of London Stock Exchange, AIM the transaction --------------------- --------------------------------------------------
For further information please contact:
hVIVO plc Trevor Phillips (Executive Chairman) +44 207 756 1300 Fleur Wood (EVP, Investor Relations & Communications) Numis Securities Limited +44 207 260 1000 Michael Meade / Freddie Barnfield (Nominated Adviser) James Black / Michael Burke (Corporate Broking) FTI Consulting Simon Conway / Victoria Foster Mitchell +44 203 727 1000
Notes to Editors:
hVIVO plc ("hVIVO") is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases. Leveraging human disease models in flu, RSV and asthma exacerbation, the hVIVO platform captures disease in motion, illuminating the entire disease life cycle from healthy to sick and back to health. Based in the UK, market leader hVIVO has conducted more than 50 clinical studies, inoculated over 2500 volunteers and has three first-in-class therapies currently in development.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHPGUMUGUPBGUC
(END) Dow Jones Newswires
January 24, 2019 05:12 ET (10:12 GMT)
1 Year Hvivo Chart |
1 Month Hvivo Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions